Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin in Japanese type 2 diabetes mellitus
NCT02314637Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Aug 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started Aug 2009; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02314637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314637.